 effect thromboxan synthesi inhibitor triflus renal hemodynam microalbuminur diabet patient triflus acid platelet-antiaggreg drug thromboxan synthesi littl effect prostacyclin product studi effect administr mg/day triflus glomerular filtrat rate gfr renal plasma flow rpf urinari albumin excret uae thromboxan alpha normotens insulin-depend diabet patient uae micrograms/min plasma plasma renin activ pra administr triflus reduct microalbuminuria micrograms/min increas rpf reduct filtrat fraction triflus signific reduct plasma pg/ml urin pg/min chang pra uae alpha metabol control arteri blood pressur chang studi result platelet-antiaggreg therapi microalbuminuria diabet patient effect reduct transglomerular hydraul pressur vasodil effer arteriol secondari thromboxan synthesi inhibit